102 related articles for article (PubMed ID: 15363466)
1. Predictive factors for response to chemotherapy in colorectal cancer patients.
Vincenzi B; Cesa AL; Santini D; Schiavon G; Grilli C; Graziano F; Tonini G
Crit Rev Oncol Hematol; 2004 Oct; 52(1):45-60. PubMed ID: 15363466
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers in prognosis of colorectal cancer and prediction of response to treatment.
Pasche B; Mulcahy M; Benson AB
Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):331-45. PubMed ID: 11969242
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics and -genetics in colorectal cancer.
Pohl A; Lurje G; Manegold PC; Lenz HJ
Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
[TBL] [Abstract][Full Text] [Related]
4. Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.
Yau T; Chan P; Ching Chan Y; Wong BC; Liang R; Epstein RJ
Aliment Pharmacol Ther; 2008 Jun; 27(11):997-1005. PubMed ID: 18363897
[TBL] [Abstract][Full Text] [Related]
5. New approaches in systemic treatment of advanced colorectal cancer: the molecular targets era.
Capdevila J; Mendez G; Macarulla T; Ramos FJ; Casado E; Tabernero J
Expert Rev Anticancer Ther; 2007 Jul; 7(7):1027-41. PubMed ID: 17627462
[TBL] [Abstract][Full Text] [Related]
6. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
Benoist S; Nordlinger B
Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for colorectal cancer--an overview of current management for surgeons.
Lawes D; Taylor I
Eur J Surg Oncol; 2005 Nov; 31(9):932-41. PubMed ID: 15979268
[TBL] [Abstract][Full Text] [Related]
8. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
9. [Biomarker for chemotherapy in patients with colorectal cancer].
Matsusaka S
Gan To Kagaku Ryoho; 2009 Jan; 36(1):11-4. PubMed ID: 19151559
[TBL] [Abstract][Full Text] [Related]
10. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
[TBL] [Abstract][Full Text] [Related]
12. Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients.
Staritz P; Kienle P; Koch M; Benner A; von Knebel Doeberitz M; Rudi J; Weitz J
J Exp Clin Cancer Res; 2004 Dec; 23(4):633-9. PubMed ID: 15743034
[TBL] [Abstract][Full Text] [Related]
13. Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group.
Giacchetti S; Bjarnason G; Garufi C; Genet D; Iacobelli S; Tampellini M; Smaaland R; Focan C; Coudert B; Humblet Y; Canon JL; Adenis A; Lo Re G; Carvalho C; Schueller J; Anciaux N; Lentz MA; Baron B; Gorlia T; Lévi F;
J Clin Oncol; 2006 Aug; 24(22):3562-9. PubMed ID: 16877722
[TBL] [Abstract][Full Text] [Related]
14. Treatment of colorectal cancer in the elderly: a review of the literature.
Golfinopoulos V; Pentheroudakis G; Pavlidis N
Cancer Treat Rev; 2006 Feb; 32(1):1-8. PubMed ID: 16337087
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer screening and treatment: review of outcomes research.
Provenzale D; Gray RN
J Natl Cancer Inst Monogr; 2004; (33):45-55. PubMed ID: 15504919
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics and biomarkers in colorectal cancer.
Strimpakos AS; Syrigos KN; Saif MW
Pharmacogenomics J; 2009 Jun; 9(3):147-60. PubMed ID: 19381163
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of mitochondrial mutations in colorectal cancer.
Lièvre A; Chapusot C; Bouvier AM; Zinzindohoué F; Piard F; Roignot P; Arnould L; Beaune P; Faivre J; Laurent-Puig P
J Clin Oncol; 2005 May; 23(15):3517-25. PubMed ID: 15908662
[TBL] [Abstract][Full Text] [Related]
18. Tumor markers in staging and prognosis of colorectal carcinoma.
Levy M; Visokai V; Lipska L; Topolcan O
Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for operable and advanced colorectal cancer.
Aschele C; Bergamo F; Lonardi S
Cancer Treat Rev; 2009 Oct; 35(6):509-16. PubMed ID: 19481872
[TBL] [Abstract][Full Text] [Related]
20. Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agents.
Jung JJ; Jeung HC; Lee JO; Kim TS; Chung HC; Rha SY
Oncol Rep; 2007 Sep; 18(3):593-9. PubMed ID: 17671706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
